Report Detail
Global Sorafenib Market Insights, Forecast to 2025
- RnM2704147 |
- 22 May, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global Sorafenib market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sorafenib market based on company, product type, end user and key regions.
This report studies the global market size of Sorafenib in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sorafenib in these regions.
This research report categorizes the global Sorafenib market by top players/brands, region, type and end user. This report also studies the global Sorafenib market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Natco Pharma
Cipla
Mylan
Market size by Product
Patented Drugs
Generic Drugs
Market size by End User
Kidney Cancer
Liver Cancer
Thyroid Cancer
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Sorafenib market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sorafenib market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sorafenib companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sorafenib submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sorafenib are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sorafenib market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Sorafenib Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Sorafenib Market Size Growth Rate by Product
- 1.4.2 Patented Drugs
- 1.4.3 Generic Drugs
- 1.5 Market by End User
- 1.5.1 Global Sorafenib Market Size Growth Rate by End User
- 1.5.2 Kidney Cancer
- 1.5.3 Liver Cancer
- 1.5.4 Thyroid Cancer
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Sorafenib Market Size
- 2.1.1 Global Sorafenib Revenue 2014-2025
- 2.1.2 Global Sorafenib Sales 2014-2025
- 2.2 Sorafenib Growth Rate by Regions
- 2.2.1 Global Sorafenib Sales by Regions
- 2.2.2 Global Sorafenib Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Sorafenib Sales by Manufacturers
- 3.1.1 Sorafenib Sales by Manufacturers
- 3.1.2 Sorafenib Sales Market Share by Manufacturers
- 3.1.3 Global Sorafenib Market Concentration Ratio (CR5 and HHI)
- 3.2 Sorafenib Revenue by Manufacturers
- 3.2.1 Sorafenib Revenue by Manufacturers (2014-2019)
- 3.2.2 Sorafenib Revenue Share by Manufacturers (2014-2019)
- 3.3 Sorafenib Price by Manufacturers
- 3.4 Sorafenib Manufacturing Base Distribution, Product Types
- 3.4.1 Sorafenib Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Sorafenib Product Type
- 3.4.3 Date of International Manufacturers Enter into Sorafenib Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Sorafenib Sales by Product
- 4.2 Global Sorafenib Revenue by Product
- 4.3 Sorafenib Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Sorafenib Breakdown Data by End User
6 North America
- 6.1 North America Sorafenib by Countries
- 6.1.1 North America Sorafenib Sales by Countries
- 6.1.2 North America Sorafenib Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Sorafenib by Product
- 6.3 North America Sorafenib by End User
7 Europe
- 7.1 Europe Sorafenib by Countries
- 7.1.1 Europe Sorafenib Sales by Countries
- 7.1.2 Europe Sorafenib Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Sorafenib by Product
- 7.3 Europe Sorafenib by End User
8 Asia Pacific
- 8.1 Asia Pacific Sorafenib by Countries
- 8.1.1 Asia Pacific Sorafenib Sales by Countries
- 8.1.2 Asia Pacific Sorafenib Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Sorafenib by Product
- 8.3 Asia Pacific Sorafenib by End User
9 Central & South America
- 9.1 Central & South America Sorafenib by Countries
- 9.1.1 Central & South America Sorafenib Sales by Countries
- 9.1.2 Central & South America Sorafenib Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Sorafenib by Product
- 9.3 Central & South America Sorafenib by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Sorafenib by Countries
- 10.1.1 Middle East and Africa Sorafenib Sales by Countries
- 10.1.2 Middle East and Africa Sorafenib Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Sorafenib by Product
- 10.3 Middle East and Africa Sorafenib by End User
11 Company Profiles
- 11.1 Bayer
- 11.1.1 Bayer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer Sorafenib Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer Sorafenib Products Offered
- 11.1.5 Bayer Recent Development
- 11.2 Natco Pharma
- 11.2.1 Natco Pharma Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Natco Pharma Sorafenib Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Natco Pharma Sorafenib Products Offered
- 11.2.5 Natco Pharma Recent Development
- 11.3 Cipla
- 11.3.1 Cipla Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Cipla Sorafenib Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Cipla Sorafenib Products Offered
- 11.3.5 Cipla Recent Development
- 11.4 Mylan
- 11.4.1 Mylan Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Mylan Sorafenib Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Mylan Sorafenib Products Offered
- 11.4.5 Mylan Recent Development
12 Future Forecast
- 12.1 Sorafenib Market Forecast by Regions
- 12.1.1 Global Sorafenib Sales Forecast by Regions 2019-2025
- 12.1.2 Global Sorafenib Revenue Forecast by Regions 2019-2025
- 12.2 Sorafenib Market Forecast by Product
- 12.2.1 Global Sorafenib Sales Forecast by Product 2019-2025
- 12.2.2 Global Sorafenib Revenue Forecast by Product 2019-2025
- 12.3 Sorafenib Market Forecast by End User
- 12.4 North America Sorafenib Forecast
- 12.5 Europe Sorafenib Forecast
- 12.6 Asia Pacific Sorafenib Forecast
- 12.7 Central & South America Sorafenib Forecast
- 12.8 Middle East and Africa Sorafenib Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Sorafenib Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Sorafenib . Industry analysis & Market Report on Sorafenib is a syndicated market report, published as Global Sorafenib Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sorafenib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
